George Eldridge

Chief Financial Officer at Aerovate Therapeutics

George has 25 years of experience in biotech, serving as CFO for several biotechnology companies including Curis, Targanta, and Proteon. George’s extensive background raising capital includes private, IPO and follow-on settings, investment banking, and M&A.

Links

Org chart

Manager

Tim Noyes

CEO

Peers

Ralph Niven

Chief Development Officer

Sanjeev Khindri

SVP, Clinical Development

Kevin Kee

VP Of Pharmaceutical Development

Reports

Muhammad Khuram Choudhry

Associate Director, Finance

Teams

CEO and Executive Team

4 members

Leadership Team

5 members

Timeline

Chief Financial Officer
Current role

View in org chart